openPR Logo
Press release

Global Angina Pectoris Drugs Market Size, Share, Forecast 2021 - 2030 | Top key players : Abbott Laboratories, AERIE PHARMACEUTICALS, INC. Abbvie, Inc. Bausch Health Companies, Inc. Merck & Co. Inc. Pfizer Inc. Teva Pharmaceutical Industries Ltd. and othe

09-22-2023 04:06 PM CET | Health & Medicine

Press release from: Spherical Insights

Global Angina Pectoris Drugs Market Size, Share

Global Angina Pectoris Drugs Market Size, Share

The Global Angina Pectoris Drugs Market Size is expected to reach USD 16.4 Billion by 2030, at a CAGR 4.5% during the forecast period 2021 to 2030

Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/1645

Comprehensive historical analysis of global market for Angina Pectoris Drugs has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the Angina Pectoris Drugs market.
The report includes growth prospects in the global Angina Pectoris Drugs market by type, application, sub segment and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.

Leading players of Angina Pectoris Drugs including:
Abbott Laboratories, AERIE PHARMACEUTICALS, INC. Abbvie, Inc. Bausch Health Companies, Inc. Merck & Co. Inc. Pfizer Inc. Teva Pharmaceutical Industries Ltd. Amorphex Therapeutics Holdings, Inc. Alcon Astellas Pharma Inc. Bayer AG Novartis AG AstraZeneca Amgen Inc. Carl Zeiss Meditec AG Gilead Sciences, Inc. Sun Pharmaceutical Industries Ltd. F. Hoffmann-La Roche Ltd. Zydus Healthcare
Market split by Segment, can be divided into:
By Drug Class Beta Blockers Calcium Channel Blockers Nitrates Angiotensin-converting Enzyme Inhibitors (ACE Inhibitors) Anti-Platelets, and Others
By End User Hospital Pharmacy Pharmaceutical Stores Others

Market segment by Region/Country including:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o Uk
o France
o Italy
o Spain
o Russia
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Rest of South America
• Middle East & Africa
o UAE
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

Buy Now : https://www.sphericalinsights.com/checkout/1645

In March 2022, the US Food and Drug Administration (FDA) approved Zydus Lifesciences to launch its Nitroglycerin Sublingual Tablets for angina in the 0.3 mg, 0.4 mg, and 0.6 mg strengths (US RLD: Nitrostat Sublingual Tablets).

What's covered in the report?
• 1. Overview of the Angina Pectoris Drugs market.
• 2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the Angina Pectoris Drugs market, based on segment.
• 3. Angina Pectoris Drugs Market trends.
• 4. Angina Pectoris Drugs Market drivers.
• 5. Analysis of major company profiles.

Reasons to buy this Market Report:

1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Angina Pectoris Drugs market.
2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging Angina Pectoris Drugs Industry.
3. Leading company profiles reveal details of key Angina Pectoris Drugs market players emerging five operations and financial performance.
4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging Angina Pectoris Drugs market with five year historical forecasts.
5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.
6. Extensive information on factors that will amplify the growth of the Angina Pectoris Drugs market over the upcoming seven years
7. Accurate estimation of the global Angina Pectoris Drugs market size
8. Exact estimations of the upcoming trends and changes observed in the consumer behavior
9. Growth of the global Angina Pectoris Drugs market across the North & South America, EMEA, Asia Pacific, and Latin America
10. Information about Angina Pectoris Drugs market growth potential
11. In-depth analysis of the industry's competitive landscape and detailed information vis-a-vis on various vendors
12. Furnishing of detailed information on the factors that will restrain the growth of the Angina Pectoris Drugs market

About the Spherical Insights
Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:
Company Name: Spherical Insights
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
Phone: +91 9561448932 (APAC)
Follow Us: LinkedIn | Facebook | Twitter

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Angina Pectoris Drugs Market Size, Share, Forecast 2021 - 2030 | Top key players : Abbott Laboratories, AERIE PHARMACEUTICALS, INC. Abbvie, Inc. Bausch Health Companies, Inc. Merck & Co. Inc. Pfizer Inc. Teva Pharmaceutical Industries Ltd. and othe here

News-ID: 3220002 • Views:

More Releases from Spherical Insights

Dairy Alternatives Market Size to Reach USD 78.7 Billion By 2033 | Top Key Players: Daiya Foods Inc., Eden Foods, Inc., Nutriops, S.L. and others
Dairy Alternatives Market Size to Reach USD 78.7 Billion By 2033 | Top Key Playe …
According to a research report published by Spherical Insights & Consulting, the Global Dairy Alternatives Market Size is to Grow from USD 27.1 Billion in 2023 to USD 78.7 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 11.2% during the projected period. The Dairy Alternatives global market research studies offer an in-depth analysis of current industry trends, development models, and methodology. Production processes, development platforms, and the actual
Global Waste Management Market Size to Reach USD 1360.3 Billion By 2032 | Top Key Players: BIFFA, SUEZ, Urbaser and others
Global Waste Management Market Size to Reach USD 1360.3 Billion By 2032 | Top Ke …
According to a research report published by Spherical Insights & Consulting, the Global Waste Management Market Size to Grow from USD 884.9 Billion in 2022 to USD 1360.3 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period. The Waste Management global market research studies offer an in-depth analysis of current industry trends, development models, and methodology. Production processes, development platforms, and the actual product
Market Research Report: Patient Monitoring Devices Market Analysis and Trends | Medtronic Plc, Mindray Medical, Omron, 3M, Boston Scientific Corporation, Covidien,, Drägerwerk AG and Co.
Market Research Report: Patient Monitoring Devices Market Analysis and Trends | …
According to a recent report by Spherical Insights & Consulting, the global patient monitoring devices market is projected to surge from USD 48.23 billion in 2023 to USD 103.82 billion by 2033, registering a robust CAGR of 7.97% during the forecast period. This growth reflects the rising demand for real-time health monitoring, the expansion of telehealth services, and increasing focus on early disease detection and chronic disease management. Request to Download
Market Research Report: Veterinary Diagnostic Imaging Market Analysis and Trends | IMV Technologies group, (IMV imaging), IDEXX Laboratories, Inc., Mindray Medical International Ltd.
Market Research Report: Veterinary Diagnostic Imaging Market Analysis and Trends …
With a robust CAGR of 7.5% forecasted between 2022 and 2030, the global veterinary diagnostic imaging market is on track to hit USD 3.15 billion by the end of the decade. Veterinary diagnostic imaging has emerged as a vital subspecialty within veterinary medicine, enabling precise, non-invasive diagnosis of diseases in animals through advanced imaging modalities. Techniques such as radiography, ultrasound, MRI, CT scans, and endoscopy are widely utilized to evaluate the

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase